opiate

In Women with Opioid Use Disorder, Treatment Initiated During Pregnancy May Improve Postpartum Outcomes

This study demonstrates higher rates of treatment continuation in postpartum women with opioid use disorders if medication treatment (methadone or buprenorphine) is initiated early and maintained throughout pregnancy.

By |2021-06-07T09:23:46-04:00June 8th, 2021|Opioids, Perinatal Substance Use|Comments Off on In Women with Opioid Use Disorder, Treatment Initiated During Pregnancy May Improve Postpartum Outcomes

Managing Opioid Dependence in Pregnancy: Outcomes in Children Exposed to Buprenorphine, Naltrexone, or Methadone

The use of opioid drugs in women of childbearing age has become a pressing public health concern.  It is clear that opiate use during pregnancy puts the mother and child at risk; opiate use during [...]

By |2017-12-07T00:26:09-04:00December 7th, 2017|Opioids, Perinatal Substance Use|Comments Off on Managing Opioid Dependence in Pregnancy: Outcomes in Children Exposed to Buprenorphine, Naltrexone, or Methadone

ACOG Releases Revised Guidelines for Treatment of Opioid Use During Pregnancy

We have been writing over the last few years about the growing problem of opioid use and abuse in women of reproductive age.  Responding to a dramatic increase in the number of women abusing opiates [...]

By |2017-09-26T10:04:35-04:00September 26th, 2017|Opioids, Perinatal Substance Use|Comments Off on ACOG Releases Revised Guidelines for Treatment of Opioid Use During Pregnancy

Opioid Abuse and Dependence in Pregnancy: Impact on Obstetrical Outcomes

In a recent study, researchers looked at the rising nationwide trend of opioid abuse and dependence in pregnancy and obstetrical outcomes in this patient population.  Previous research has focused on neonatal outcomes, such as neonatal abstinence syndrome; however, maternal complications have not been well-studied.  In this study, data was collected from the Nationwide Inpatient Sample (NIS), including nearly 57 million American women who were admitted for obstetric delivery between the years 1998-2011.  Overall 113,105 of those women (0.2%) were identified as abusing or being dependent on opioids.  The prevalence increased by 127% from the beginning of the study in 1998 until its completion in 2011, reflecting the growing opioid epidemic.   The increase was mostly represented in women 20 to 34 years or age.

By |2015-02-13T10:11:40-04:00January 22nd, 2015|Opioids, Perinatal Substance Use|Comments Off on Opioid Abuse and Dependence in Pregnancy: Impact on Obstetrical Outcomes

Methadone and Breastfeeding

Up until 2001, the American Academy of Pediatrics (AAP) recommended that methadone was compatible with breastfeeding in women taking less than 20 mg per day.  Because most women on methadone maintenance therapy typically require 50 to 15o mg of methadone per day during pregnancy, this meant that most women on methadone were not able to breastfeed. However, the dose restriction for methadone was eliminated in 2001, a decision driven by several studies indicating that the levels of methadone secreted into human breast milk were relatively low.

By |2017-05-05T18:31:03-04:00March 21st, 2011|Breastfeeding & Medications, Opioids, Perinatal Substance Use|Comments Off on Methadone and Breastfeeding
Go to Top